GlassScriptPhysician profile
Kimberly A Link
NPI 1063584209
$2,122.91
in general payments reported to CMS, 2019-2025
19 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $583 · 2022: $464 · 2023: $295 · 2024: $455 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.94 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $304.15 | 2021-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $253.69 | 2021-2025 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $222.64 | 2021-2025 | Caplyta |
| Alkermes, INC. | $158.88 | 2021-2023 | Lybalvi |
| Vanda Pharmaceuticals INC. | $138.77 | 2021-2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $135.61 | 2021-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Corium, LLC | $125.00 | 2023 | Azstarys |
| Bausch Health US, LLC | $90.85 | 2021 | |
| Axsome Therapeutics, INC. | $80.30 | 2024-2025 | Auvelity |
| Biogen, INC. | $35.02 | 2024 | Zurzuvae |
| Sage Therapeutics, LLC | $31.73 | 2021 | |
| Neurocrine Biosciences, INC. | $29.03 | 2021-2022 | |
| Indivior INC. | $24.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.81 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $20.23 | 2023 | Wakix |
| Boston Scientific Corporation | $19.61 | 2024 | Watchman Flx |
| Ironshore Pharmaceuticals INC. | $17.29 | 2023 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.